Published in J Mol Cell Cardiol on December 15, 2015
Integrins and integrin-related proteins in cardiac fibrosis. J Mol Cell Cardiol (2015) 0.80
Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications. Can J Cardiol (2016) 0.80
RAGE and glyoxalase in kidney disease. Glycoconj J (2016) 0.79
Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol (2017) 0.78
The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest (2017) 0.77
Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus. Cardiovasc Diabetol (2016) 0.75
Crossing Into the Next Frontier of Cardiac Extracellular Matrix Research. Circ Res (2016) 0.75
AGE-RAGE interaction in the TGFβ2-mediated epithelial to mesenchymal transition of human lens epithelial cells. Glycoconj J (2016) 0.75
Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions. Glycoconj J (2016) 0.75
Estrogen deprivation aggravates cardiac hypertrophy in non-obese type 2 diabetic Goto-kakizaki (GK) rats. Biosci Rep (2017) 0.75
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med (2007) 9.51
Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation (2006) 5.31
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol (1972) 4.86
CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res (2005) 4.14
Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med (2004) 4.05
Cardiac fibroblast: the renaissance cell. Circ Res (2009) 4.01
Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol (2003) 3.78
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med (2015) 3.67
Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity (2014) 3.54
Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation (2003) 3.30
Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes (2007) 3.20
Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation (2007) 3.12
Glycemic control and heart failure among adult patients with diabetes. Circulation (2001) 2.99
Cardiac remodeling in obesity. Physiol Rev (2008) 2.95
Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation (2008) 2.61
Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest (1977) 2.53
Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol (1995) 2.46
TGF-β signaling in fibrosis. Growth Factors (2011) 2.42
Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol (2010) 2.35
Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J (2013) 2.21
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest (2001) 2.20
Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation (2007) 2.14
Diabetes and hypertension: the bad companions. Lancet (2012) 2.10
A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation (1990) 2.05
Matricellular proteins in cardiac adaptation and disease. Physiol Rev (2012) 2.01
Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest (1994) 1.99
The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol (2014) 1.99
The pathogenesis of cardiac fibrosis. Cell Mol Life Sci (2013) 1.96
Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res (2010) 1.94
Adiponectin actions in the cardiovascular system. Cardiovasc Res (2006) 1.92
Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care (2003) 1.82
Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest (2010) 1.78
An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLoS One (2012) 1.76
Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc Res (2000) 1.73
Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation (2010) 1.72
The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol (1994) 1.68
Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes (2007) 1.67
Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes (2002) 1.67
Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol (2013) 1.61
Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation. Circ Res (2013) 1.61
Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis. Am Heart J (2011) 1.59
Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. Biochem Biophys Res Commun (2005) 1.58
Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes (2008) 1.57
AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension (2003) 1.57
The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res (2003) 1.50
Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Dis Model Mech (2011) 1.40
Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha. Arterioscler Thromb Vasc Biol (2008) 1.39
Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation (1998) 1.39
Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism. Diabetes (2007) 1.39
Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. Am J Physiol Heart Circ Physiol (2009) 1.38
Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart. Hypertension (2009) 1.36
Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. Am J Physiol Heart Circ Physiol (2009) 1.36
Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res (2004) 1.35
The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice. Circulation (2012) 1.32
Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol (2001) 1.30
Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res (2005) 1.30
Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol (2007) 1.27
Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology (2007) 1.26
Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy. Lancet (2015) 1.23
Cardiovascular and autonomic phenotype of db/db diabetic mice. Exp Physiol (2009) 1.23
Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness. Circulation (2011) 1.22
Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells. J Biol Chem (2006) 1.21
Myocardial structure, function, and scar in patients with type 1 diabetes mellitus. Circulation (2011) 1.20
Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes. Diabetes (2010) 1.20
Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol (1993) 1.19
Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats. Endocrinology (2013) 1.15
Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production. Am J Physiol Heart Circ Physiol (2008) 1.15
IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J Immunol (2013) 1.14
Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes. Am J Physiol Heart Circ Physiol (2009) 1.13
The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions. Circulation (2011) 1.12
Noncoding RNAs and myocardial fibrosis. Nat Rev Cardiol (2014) 1.12
WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death. J Biol Chem (2009) 1.12
Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am J Pathol (2010) 1.11
High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. J Am Soc Nephrol (1999) 1.11
Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade. Heart (2013) 1.09
Risk factors for sudden cardiac death in post-menopausal women. J Am Coll Cardiol (2012) 1.08
Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J Clin Endocrinol Metab (2005) 1.07
Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc Pathol (2004) 1.06
Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis (2013) 1.05
Central leptin signaling is required to normalize myocardial fatty acid oxidation rates in caloric-restricted ob/ob mice. Diabetes (2011) 1.05
Adiponectin inhibits lipopolysaccharide-induced adventitial fibroblast migration and transition to myofibroblasts via AdipoR1-AMPK-iNOS pathway. Mol Endocrinol (2009) 1.05
Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm (2012) 1.04
Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. Cardiovasc Res (2007) 1.04
Chemokines and cardiac fibrosis. Front Biosci (Schol Ed) (2009) 1.03
Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy. PLoS One (2013) 1.01
Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy. Semin Nephrol (2012) 1.00
Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice. Diabetes (2012) 1.00
Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med (2014) 1.00
Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes (2010) 1.00
Leptin is a coactivator of TGF-beta in unilateral ureteral obstructive kidney disease. Am J Physiol Renal Physiol (2007) 0.99
Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration. Endocrinology (2011) 0.99
Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease. Am J Pathol (1981) 0.98
Crosstalk between the renin-angiotensin system and the advance glycation end product axis in the heart: role of the cardiac fibroblast. J Cardiovasc Transl Res (2012) 0.98
TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. J Clin Invest (2014) 0.98
Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus. Heart Vessels (1985) 0.97
Leptin's regulation of obesity-induced cardiac extracellular matrix remodeling. Cardiovasc Toxicol (2011) 0.97
Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation (2015) 0.96
Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol (2013) 1.61